{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:28:22Z","timestamp":1790137702492,"version":"4.0.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.jaad.2001.07.001","type":"journal-article","created":{"date-parts":[[2004,7,22]],"date-time":"2004-07-22T15:46:18Z","timestamp":1090511178000},"page":"73-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"S","title":["Gemcitabine-associated scleroderma-like changes of the lower extremities"],"prefix":"10.1016","volume":"51","author":[{"given":"Didier","family":"Bessis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Legouffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Guilhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2001.07.001_BIB1","first-page":"4417","article-title":"Evaluation of the antitumor activity of gemcitabine","volume":"50","author":"Hertel","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2001.07.001_BIB2","first-page":"6110","article-title":"Action of gemcitabine on DNA synthesis","volume":"51","author":"Huang","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2001.07.001_BIB3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/bjc.1998.750","article-title":"The role of gemcitabine in the treatment of other tumours","volume":"78","author":"Carmichael","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaad.2001.07.001_BIB4","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1200\/JCO.1997.15.12.3441","article-title":"Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer","volume":"15","author":"Moore","year":"1977","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2001.07.001_BIB5","first-page":"31","article-title":"Gemcitabine in bladder cancer","volume":"27","author":"Sternberg","year":"2000","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jaad.2001.07.001_BIB6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00001813-199803000-00001","article-title":"Gemcitabine\u2013a safety review","volume":"9","author":"Aapro","year":"1998","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.jaad.2001.07.001_BIB7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJM199902253400814","article-title":"Anal pruritus after cancer chemotherapy with gemcitabine","volume":"340","author":"Hejna","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2001.07.001_BIB8","first-page":"552","article-title":"Gemcitabine-induced severe extremity edema with muscle contractures and subsequent prevention with prednisone","volume":"2","author":"Geffen","year":"2000","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.jaad.2001.07.001_BIB9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00001813-200001000-00003","article-title":"Time- and dose-limiting erysipeloid rash confined to areas of lymphedema following treatment with gemcitabine\u2013a report of three cases","volume":"11","author":"Brandes","year":"2000","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.jaad.2001.07.001_BIB10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0738-081X(98)00006-6","article-title":"Drug-induced scleroderma and sclerodermiform conditions","volume":"16","author":"Haustein","year":"1998","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2001.07.001_BIB11","first-page":"294","article-title":"Scleroderma in association with the use of bleomycin: a report of 3 cases","volume":"19","author":"Kerr","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2001.07.001_BIB12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0190-9622(00)90233-0","article-title":"Scleroderma-like reaction induced by uracil-tegafur (UFT), a second-generation anticancer agent","volume":"42","author":"Kono","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2001.07.001_BIB13","first-page":"55","article-title":"Raynaud's phenomenon possibly induced by a compound drug of tegafur and uracil","volume":"9","author":"Sheishima","year":"1999","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2001.07.001_BIB14","first-page":"712","article-title":"Scleroderma of the shoulders after treatment with combined bleomycin and radiotherapy","volume":"121","author":"Marck","year":"1994","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2001.07.001_BIB15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/1097-0142(19950701)76:1<110::AID-CNCR2820760117>3.0.CO;2-9","article-title":"Docetaxel (Taxotere) associated scleroderma-like changes of the lower extremities","volume":"76","author":"Battafarano","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2001.07.001_BIB16","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1078::AID-CNCR19>3.0.CO;2-T","article-title":"Cutaneous fibrosis induced by docetaxel: a case report","volume":"88","author":"Cleveland","year":"2000","journal-title":"Cancer"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204005080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204005080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:34:12Z","timestamp":1759268052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962204005080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0190962204005080"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2001.07.001","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gemcitabine-associated scleroderma-like changes of the lower extremities","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2001.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}